Table S1 from Phosphoproteomics Reveals MAPK Inhibitors Enhance MET- and EGFR-Driven AKT Signaling in <i>KRAS</i>-Mutant Lung Cancer
收藏NIAID Data Ecosystem2026-05-09 收录
数据链接：
官方服务：
资源简介：
Table S1. List of phosphopeptides identified by phosphoproteomics experiments in A427 and A549 cell line treated with vehicle control (DMSO) or MEK inhibitor (selumetinib)
创建时间：
2016-10-01
